Rolapitant For Prevention Of Chemotherapy-Induced Nausea And Vomiting In Patients Receiving Moderately Emetogenic Chemotherapy In The United States- Subgroup Analysis From A Randomized Phase Iii Trial
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1635
https://www.valueinhealthjournal.com/article/S1098-3015(16)01703-4/fulltext
Title :
Rolapitant For Prevention Of Chemotherapy-Induced Nausea And Vomiting In Patients Receiving Moderately Emetogenic Chemotherapy In The United States- Subgroup Analysis From A Randomized Phase Iii Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01703-4&doi=10.1016/j.jval.2016.03.1635
First page :
A135
Section Title :
Cancer - Clinical Outcomes Studies
Open access? :
No
Section Order :
223